Your browser doesn't support javascript.
loading
Cognitive Dysfunction in Non-CNS Metastatic Cancer: Comparing Brain Metastasis, Non-CNS Metastasis, and Healthy Controls.
Collette, Christopher; Willhelm, Gabrielle; Del Bene, Victor A; Aita, Stephen L; Marotta, Dario; Myers, Terina; Anderson, Joseph; Gammon, Meredith; Gerstenecker, Adam; Nabors, L Burt; Fiveash, John; Triebel, Kristen L.
Afiliação
  • Collette C; Department of Neurology, The University of Alabama at Birmingham Heersink School of Medicine, Birmingham, Alabama, USA.
  • Willhelm G; Department of Neurology, The University of Alabama at Birmingham Heersink School of Medicine, Birmingham, Alabama, USA.
  • Del Bene VA; Department of Neurology, The University of Alabama at Birmingham Heersink School of Medicine, Birmingham, Alabama, USA.
  • Aita SL; Geisel School of Medicine at Dartmouth, Hanover, New Hampshire, USA.
  • Marotta D; Department of Mental Health, VA Maine Healthcare System, Augusta, Maine, USA.
  • Myers T; Department of Neurology, The University of Alabama at Birmingham Heersink School of Medicine, Birmingham, Alabama, USA.
  • Anderson J; Department of Neurology, The University of Alabama at Birmingham Heersink School of Medicine, Birmingham, Alabama, USA.
  • Gammon M; Department of Neurology, The University of Alabama at Birmingham Heersink School of Medicine, Birmingham, Alabama, USA.
  • Gerstenecker A; Department of Neurology, The University of Alabama at Birmingham Heersink School of Medicine, Birmingham, Alabama, USA.
  • Nabors LB; Department of Neurology, The University of Alabama at Birmingham Heersink School of Medicine, Birmingham, Alabama, USA.
  • Fiveash J; Department of Neurology, The University of Alabama at Birmingham Heersink School of Medicine, Birmingham, Alabama, USA.
  • Triebel KL; Department of Radiation Oncology, The University of Alabama at Birmingham Heersink School of Medicine, Birmingham, Alabama, USA.
Cancer Invest ; : 1-11, 2024 Jul 15.
Article em En | MEDLINE | ID: mdl-39007916
ABSTRACT
Limited research has compared cognition of people with non-central nervous system metastatic cancer (NCM) vs. metastatic brain cancer (BM). This prospective cross-sectional study was comprised 37 healthy controls (HC), 40 NCM, and 61 BM completing 10 neuropsychological tests. The NCM performed below HCs on processing speed and executive functioning tasks, while the BM group demonstrated lower performance across tests. Tasks of processing speed, verbal fluency, and verbal memory differentiated the clinical groups (BM < NCM). Nearly 20% of the NCM group was impaired on at least three neuropsychological tests whereas approximately 40% of the BM group demonstrated the same level of impairment.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Cancer Invest Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Cancer Invest Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Estados Unidos